Case report demonstrates low dual-tracer uptake in periprostatic mass, indicating benign features.
A 68-year-old male patient presented with a 4-month history of dysuria and an elevated prostate-specific antigen (PSA) level of 21.4 ng/mL. Contrast-enhanced CT revealed a purely extraprostatic 5-cm anterior periprostatic mass. 18 F-fluorodeoxyglucose ( 18 F-FDG) and 68 Ga-prostate-specific membrane antigen ( 68 Ga-PSMA) positron emission tomography/magnetic resonance imaging (PET/MRI) revealed low dual-tracer uptake (maximum standardized uptake value [SUV max ] = 2.4 for both tracers) with benign features, including neural tumor-specific T2 septations, preserved apparent diffusion coefficient (ADC), and type 2 plateau enhancement. Histopathological analysis confirmed the diagnosis of periprostatic perineurioma (epithelial membrane antigen [EMA]+/CD34+/S100-, Ki67 index 1%). This case highlights the value of multimodal PET/MRI for accurate characterization of pelvic tumors, particularly in distinguishing rare benign entities from malignancy.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: